These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33417587)

  • 41. First Round of External Quality Assessment Scheme for SARS-CoV-2 Laboratories During the COVID-19 Pandemic in Thailand.
    Saeng-Aroon S; Changsom D; Boonmuang R; Waicharoen S; Buayai K; Okada P; Uppapong B; Chittaganpitch M; Soisangwan P; Praphasiri P; Skaggs BA
    Health Secur; 2023; 21(3):183-192. PubMed ID: 37196204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SMART-on-FHIR implemented over i2b2.
    Wagholikar KB; Mandel JC; Klann JG; Wattanasin N; Mendis M; Chute CG; Mandl KD; Murphy SN
    J Am Med Inform Assoc; 2017 Mar; 24(2):398-402. PubMed ID: 27274012
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Development of a national proficiency test for SARS-CoV-2 detection by PCR in Colombia.
    Dávila SL; Leguizamón JE; León AF; Holguín K; Barros EC; Gomez SY
    J Glob Health; 2023 Oct; 13():06029. PubMed ID: 37824175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Setting up a PCR Laboratory for the Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Wang QY; Li Q
    Clin Lab; 2021 Dec; 67(12):. PubMed ID: 34910437
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Routine Laboratory Blood Tests Predict SARS-CoV-2 Infection Using Machine Learning.
    Yang HS; Hou Y; Vasovic LV; Steel PAD; Chadburn A; Racine-Brzostek SE; Velu P; Cushing MM; Loda M; Kaushal R; Zhao Z; Wang F
    Clin Chem; 2020 Nov; 66(11):1396-1404. PubMed ID: 32821907
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FHIRedApp: a LEAP in health information technology for promoting patient access to their medical information.
    Khurshid A; Oliveira E; Nordquist E; Lakshminarayanan V; Abrol V
    JAMIA Open; 2021 Oct; 4(4):ooab109. PubMed ID: 35155997
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An Agreement of Antigen Tests on Oral Pharyngeal Swabs or Less Invasive Testing With Reverse Transcription Polymerase Chain Reaction for Detecting SARS-CoV-2 in Adults: Protocol for a Prospective Nationwide Observational Study.
    Schneider UV; Knudsen JD; Koch A; Kirkby NS; Lisby JG
    JMIR Res Protoc; 2022 May; 11(5):e35706. PubMed ID: 35394449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of False-Positive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Molecular Results in a High-Throughput Open-Platform System.
    Martinez RJ; Pankratz N; Schomaker M; Daniel J; Beckman K; Karger AB; Thyagarajan B; Ferreri P; Yohe SL; Nelson AC
    J Mol Diagn; 2021 Sep; 23(9):1085-1096. PubMed ID: 34116245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implementation of Interoperable Healthcare Standards for Community Healthcare.
    Bae YS; Park Y; Lee SM; You H; Park Y; Lee H; Yoon HJ
    Stud Health Technol Inform; 2023 May; 302():372-373. PubMed ID: 37203691
    [TBL] [Abstract][Full Text] [Related]  

  • 50. KETOS: Clinical decision support and machine learning as a service - A training and deployment platform based on Docker, OMOP-CDM, and FHIR Web Services.
    Gruendner J; Schwachhofer T; Sippl P; Wolf N; Erpenbeck M; Gulden C; Kapsner LA; Zierk J; Mate S; Stürzl M; Croner R; Prokosch HU; Toddenroth D
    PLoS One; 2019; 14(10):e0223010. PubMed ID: 31581246
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical evaluation of a fully automated, laboratory-developed multiplex RT-PCR assay integrating dual-target SARS-CoV-2 and influenza A/B detection on a high-throughput platform.
    Nörz D; Hoffmann A; Aepfelbacher M; Pfefferle S; Lütgehetmann M
    J Med Microbiol; 2021 Feb; 70(2):. PubMed ID: 33404401
    [No Abstract]   [Full Text] [Related]  

  • 52. Diagnostics for COVID-19: A case for field-deployable, rapid molecular tests for community surveillance.
    Frimpong M; Amoako YA; Anim KB; Ahor HS; Yeboah R; Arthur J; Dakorah JS; Gborgblovor D; Akrofi S; Sekyi-Djan P; Owusu M; Sylverken AA; Binger T; Phillips RO
    Ghana Med J; 2020 Dec; 54(4 Suppl):71-76. PubMed ID: 33976444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interoperable genetic lab test reports: mapping key data elements to HL7 FHIR specifications and professional reporting guidelines.
    Khalifa A; Mason CC; Garvin JH; Williams MS; Del Fiol G; Jackson BR; Bleyl SB; Alterovitz G; Huff SM
    J Am Med Inform Assoc; 2021 Nov; 28(12):2617-2625. PubMed ID: 34569596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measures implemented in the school setting to contain the COVID-19 pandemic.
    Krishnaratne S; Littlecott H; Sell K; Burns J; Rabe JE; Stratil JM; Litwin T; Kreutz C; Coenen M; Geffert K; Boger AH; Movsisyan A; Kratzer S; Klinger C; Wabnitz K; Strahwald B; Verboom B; Rehfuess E; Biallas RL; Jung-Sievers C; Voss S; Pfadenhauer LM
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015029. PubMed ID: 35037252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Standardization and Comparison of Emergency Use Authorized COVID-19 Assays and Testing Laboratories.
    Rao A; Lin J; Parsons R; Greenleaf M; Westbrook A; Lai E; Bowers HB; McClendon K; O'Sick W; Baugh T; Sifford M; Sullivan JA; Lam WA; Bassit L
    medRxiv; 2023 Nov; ():. PubMed ID: 37986832
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Validation and Testing of Fast Healthcare Interoperability Resources Standards Compliance: Data Analysis.
    Walonoski J; Scanlon R; Dowling C; Hyland M; Ettema R; Posnack S
    JMIR Med Inform; 2018 Oct; 6(4):e10870. PubMed ID: 30355549
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
    Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
    Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A future-proof architecture for telemedicine using loose-coupled modules and HL7 FHIR.
    Gøeg KR; Rasmussen RK; Jensen L; Wollesen CM; Larsen S; Pape-Haugaard LB
    Comput Methods Programs Biomed; 2018 Jul; 160():95-101. PubMed ID: 29728251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Technical and health governance aspects of the External Quality Assessment Scheme for the SARS-CoV-2 molecular tests: institutional experience performed in all clinical laboratories of a Regional Health Service.
    Di Gaudio F; Brunacci G; Contino F; Gallo A; Centineo F
    Clin Chem Lab Med; 2023 Jan; 61(1):173-179. PubMed ID: 36114825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.